Stock comparison
AMGEN INC is 52.2x more valuable than Beam Therapeutics Inc. by market capitalization ($196.28 B vs $3.76 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 52.2x more valuable than Beam Therapeutics Inc. by market capitalization ($196.28 B vs $3.76 B).
Market value leader
AMGN
AMGEN INC is 52.2x more valuable than Beam Therapeutics Inc. by market capitalization ($196.28 B vs $3.76 B).
Revenue leader
AMGN
BEAM: $139.74M vs AMGN: $36.75B.
Profit leader
AMGN
BEAM: -$79.99M vs AMGN: $7.71B.
Margin leader
AMGN
BEAM: -57.2% vs AMGN: 21.0% net margin.
| Metric | BEAM | AMGN |
|---|---|---|
| Market cap | $3.76 B | $196.28 B |
| US-listed rank | #1657 | #75 |
| Revenue (latest FY) | $139.74M | $36.75B |
| Net income (latest FY) | -$79.99M | $7.71B |
| Net margin | -57.2% | 21.0% |
| P/E (trailing FY) | - | 25.5x |
| SEC filings | 488 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 52.2x more valuable than Beam Therapeutics Inc. by market capitalization ($196.28 B vs $3.76 B).
In their latest fiscal years, Beam Therapeutics Inc. reported $139.74M in revenue while AMGEN INC reported $36.75B.
Full pages: Beam Therapeutics Inc. and AMGEN INC, or browse the full rankings.